Log in
Enquire now
‌

US Patent 7531180 Chimeric alphavirus replicon particles

Patent 7531180 was granted and assigned to Novartis on May, 2009 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Current Assignee
Novartis
Novartis
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
7531180
Date of Patent
May 12, 2009
Patent Application Number
10123101
Date Filed
April 11, 2002
Patent Citations Received
‌
US Patent 11771747 Multiepitope vaccine cassettes
‌
US Patent 12060568 Temperature-based transient delivery of nucleic acids and proteins to cells and tissues
0
‌
US Patent 12109257 Alphavirus neoantigen vectors
0
‌
US Patent 12134777 Alphavirus replicon vector and immunotherapy by administering same
0
Patent Primary Examiner
‌
Mary E. Mosher
Patent abstract

Chimeric alphaviruses and alphavirus replicon particles are provided including methods of making and using same. Specifically, alphavirus particles are provided having nucleic acid molecules derived from one or more alphaviruses and structural proteins (capsid and/or envelope) from at least two or more alphaviruses. Methods of making, using, and therapeutic preparations containing the chimeric alphavirus particle, are disclosed.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 7531180 Chimeric alphavirus replicon particles

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.